CJC-1295 (no DAC) + Ipamorelin

What it is

This blend combines CJC-1295 without DAC and ipamorelin, two synthetic peptides investigated within the growth hormone axis. The first component corresponds to the analog known as Modified GRF (1-29), with sequence changes relative to the natural GHRH fragment. The no-DAC specification matters: it is not the variant incorporating that chemical complex. Ipamorelin is a five-amino-acid peptide associated with the ghrelin receptor. Combining them allows exploration of two different receptors within one endocrine system, without equating the components or assuming that their individual properties automatically describe the blend. Component identity remains essential to interpreting any experiment.

This material is research grade and is not a medicine. Published observations depend on the experimental system and its controls; they are not a promise for people. Documentation of identity, purity, and origin must be evaluated independently of any scientific hypothesis or proposed biological mechanism.

Origin

Both components are synthetic. The GHRH analog derives from work on active fragments and sequence modifications developed in endocrine laboratories during the closing decades of the twentieth century. Ipamorelin was described in industrial research programs in the 1990s. The commercial blend has no natural origin as a single biological entity.

How it is studied

Researchers use cellular systems with defined receptors and animal endocrine models to compare individual components and blends. They measure growth hormone release, signaling patterns over time, and IGF-1. Precise identification of the no-DAC variant is necessary for interpreting comparisons; human data on this specific blend are limited and cannot be inferred from another formulation. These studies make no promises of personal effects. Available human information has limitations and does not amount to evidence for this commercial batch. Interpretation requires reviewing controls, reproducibility, analytical identity, and differences between models before drawing scientific conclusions about the observations.